a16z Joint Creation: It is unreasonable to be bearish on AI investment portfolio under the background of continuous progress in open source AI
Shaw, the co-founder of ai16z, posted on social media platform X stating that it is unreasonable to be pessimistic about the AI investment portfolio against the backdrop of continuous improvement and cost reduction in open-source AI technology.
He emphasized that advancements in open-source AI technology can allow all AI products and intelligent agents to improve their performance levels for free. This technological dividend will continue to drive the development of the entire AI industry.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
GSK (GSK.US) strengthens its oncology pipeline with acquisition worth up to $750 million for EnmuBio's trispecific TCE, targeting multiple myeloma
GlaxoSmithKline announced on Tuesday that it has reached an agreement with Chinese biotechnology company ImmuneOnco to acquire the global rights to one of the latter’s trispecific T-cell engagers (TCE) for a total transaction amount of up to $750 million.
Alphabet's Waymo, Local Partners Plan 2027 Tokyo Autonomous Taxi Launch
Germany's DAX 40 fell to 25,200 points, down 0.8% in 24 hours
Borr Drilling Divests Mexican Oil Drilling Joint Ventures
Crypto prices
More
